Suppr超能文献

超声内镜检查联合或不联合纵隔镜检查用于可切除肺癌:一项随机临床试验。

Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial.

机构信息

Department of Surgery, Máxima MC, Veldhoven, the Netherlands.

Amsterdam UMC Location University of Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, Methodology, Amsterdam, the Netherlands.

出版信息

J Clin Oncol. 2023 Aug 1;41(22):3805-3815. doi: 10.1200/JCO.22.01728. Epub 2023 Apr 5.

Abstract

PURPOSE

Resectable non-small-cell lung cancer (NSCLC) with a high probability of mediastinal nodal involvement requires mediastinal staging by endosonography and, in the absence of nodal metastases, confirmatory mediastinoscopy according to current guidelines. However, randomized data regarding immediate lung tumor resection after systematic endosonography versus additional confirmatory mediastinoscopy before resection are lacking.

METHODS

Patients with (suspected) resectable NSCLC and an indication for mediastinal staging after negative systematic endosonography were randomly assigned to immediate lung tumor resection or confirmatory mediastinoscopy followed by tumor resection. The primary outcome in this noninferiority trial (noninferiority margin of 8% that previously showed to not compromise survival, < .0250) was the presence of unforeseen N2 disease after tumor resection with lymph node dissection. Secondary outcomes were 30-day major morbidity and mortality.

RESULTS

Between July 17, 2017, and October 5, 2020, 360 patients were randomly assigned, 178 to immediate lung tumor resection (seven dropouts) and 182 to confirmatory mediastinoscopy first (seven dropouts before and six after mediastinoscopy). Mediastinoscopy detected metastases in 8.0% (14/175; 95% CI, 4.8 to 13.0) of patients. Unforeseen N2 rate after immediate resection (8.8%) was noninferior compared with mediastinoscopy first (7.7%) in both intention-to-treat (Δ, 1.03%; UL 95% CIΔ, 7.2%; = .0144) and per-protocol analyses (Δ, 0.83%; UL 95% CIΔ, 7.3%; = .0157). Major morbidity and 30-day mortality was 12.9% after immediate resection versus 15.4% after mediastinoscopy first ( = .4940).

CONCLUSION

On the basis of our chosen noninferiority margin in the rate of unforeseen N2, confirmatory mediastinoscopy after negative systematic endosonography can be omitted in patients with resectable NSCLC and an indication for mediastinal staging.

摘要

目的

可切除的非小细胞肺癌(NSCLC)伴有纵隔淋巴结受累的高概率需要通过内镜超声进行纵隔分期,如果没有淋巴结转移,则根据当前指南进行确认性纵隔镜检查。然而,目前缺乏关于系统性内镜超声检查后立即进行肺部肿瘤切除与切除前进行额外确认性纵隔镜检查的随机数据。

方法

对(疑似)可切除的 NSCLC 患者进行系统内镜超声检查后,如果有纵隔分期的指征,则随机分配至立即进行肺部肿瘤切除或确认性纵隔镜检查后再进行肿瘤切除。本非劣效性试验(非劣效性边界为 8%,此前研究表明这不会影响生存,<.0250)的主要结局是在进行淋巴结清扫的肺部肿瘤切除后出现意外 N2 疾病。次要结局为 30 天主要发病率和死亡率。

结果

在 2017 年 7 月 17 日至 2020 年 10 月 5 日期间,共随机分配了 360 名患者,其中 178 名患者立即进行肺部肿瘤切除(7 名患者退出),182 名患者首先进行确认性纵隔镜检查(纵隔镜检查前有 7 名患者退出,检查后有 6 名患者退出)。纵隔镜检查发现 175 名患者中有 8.0%(14/175;95%CI,4.8 至 13.0)存在转移。立即切除后的意外 N2 率(8.8%)在意向治疗(Δ,1.03%;UL 95%CIΔ,7.2%;=.0144)和方案分析(Δ,0.83%;UL 95%CIΔ,7.3%;=.0157)中均不劣于纵隔镜检查第一组(7.7%)。立即切除后主要发病率和 30 天死亡率为 12.9%,而纵隔镜检查第一组为 15.4%(=.4940)。

结论

根据我们在意外 N2 发生率方面选择的非劣效性边界,在有纵隔分期指征且可切除的 NSCLC 患者中,系统性内镜超声检查阴性后可省略确认性纵隔镜检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fc2/10419618/0c23581ca7dd/jco-41-3805-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验